30 closest matches · ranked by relevance
Overweight · Obesity · Diabetes
Primary: Change in Body Weight — -1.7; -.2; -4.3; -3.0 pounds — p=.296
Chronic Kidney Diseases · Hypertension · Diabetes
Primary: Number of Participants With CKD Diagnosis — 417; 389 Participants — p=.21
Hypertension · Type 2 Diabetes
Primary: The Change in EEQ (Emotional Eater Questionnaire) Score is the Primary Outcome Measure in This Study. — -1.7; -3.2 Scores on a scale
Chronic Disease
Primary: PROMIS Global Health Measure Score — 46.27; 46.21; 44.92; 46.38 T-score
Chronic Kidney Disease
Primary: Mortality — 0; 0 percentage of mortality
Chronic Obstructive Pulmonary Disease
Primary: Time Spent in Physical Activity as Measured by Upright Time (Minutes Per Day) Monitored by ActivPal Monitor — 278; 269; 293; 285 minutes per day
Chronic Kidney Disease
Primary: Systolic Blood Pressure (SBP) — 135.1; 134.4 mmHg — p=0.57
Long Covid19
Primary: Assessment of the Impact of Health-related Quality of Life — 4; 3; 4; 6 Participants
Chronic Kidney Disease · Diabetes · Hypertension
Primary: All Cause Hospitalizations for Patients With a Triad of Chronic Kidney Disease, Diabetes and Hypertension — 20.7; 21.12 percentage of participants hospitalized
Chronic Renal Insufficiency
Primary: PTH (Parathyroid Hormone) Adherence — 0.23; 0.28 probability of having a PTH measured — p=0.04
Multimorbidity · Quality of Life · Symptom Management
Primary: Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Pain — 5; 4; 5 score on a scale
Chronic Obstructive Pulmonary Disease
Primary: Hospital Readmission — 1.12; 1.7 hospital readmissions
Chronic Obstructive Pulmonary Disease (COPD) · Congestive Heart Failure (CHF) · Sleep Disordered Breathing (SDB)
Primary: Time to First Hospitalization — 255; 224 days — p=0.342
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With Any Adverse Events (AEs) and Serious AEs (SAEs) — 120; 27 Participants
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change in Flow Mediated Dilation — 0.26; -1.5 percentage of flow mediated dilation
Metabolic Syndrome
Primary: Feasibility of the Diet Intervention — 4782 prescribed diet visits
Diabetes · Asthma · Chronic Obstructive Pulmonary Disease
Primary: Patient Activation — 61.87; 63.73; 63.82; 63.15 score on a scale — p=0.0211
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Multiple Chronic Conditions
Primary: Treatment Burden — 11.9; 11.6; 12.7; 17.9 score on a scale
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders
Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
Inflammation · Insulin Sensitivity
Primary: Insulin Sensitivity — 50.2; 40.7; 57.5; 42.3 μmol/kgFFM/min
Diabetes Mellitus, Type 2
Primary: Documentation of Diabetes Goal — 21; 27; 29; 23 Participants — p=<0.01
Diabetes Mellitus
Primary: Change in Confidence in Ability to Perform Teamwork — 1.40; -0.12 units of a scale — p=0.04
Patient Empowerment · Coronary Artery Disease
Primary: Compliance Questionnaire Scores of the Participants — 22.25; 22.53 score on a scale
Psoriasis
Primary: Change in Histology
Heart Failure · Chronic Obstructive Pulmonary Disease · Chronic Kidney Disease
Primary: Quality of Life as Measured by SF-36 — 42.77; 42.39; 43.77; 48.31 score on a scale — p=.48
Heart Failure · Pulmonary Disease, Chronic Obstructive · Emphysema
Primary: Function Assessment of Chronic Illness Therapy-General (FACT-G) — 59.0; 54.0 score on a scale
Diabetes Mellitus, Type 1
Primary: Time in Range (%) — 64 percentage of time (minutes)
Diabetes
Primary: Change in Weight — 2.1; 0.2 pounds
Type 2 Diabetes
Primary: Mean Change in Percent of Hemoglobin A1C — -1.1; -0.8; -0.8 percentage of hemoglobin A1C — p=0.8